Market Scenario:

Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2585

Segments:
Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others. On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.
Key Players for Middle-East and Africa Ischemic Heart Disease Market:
Some of the key players in MEA Ischemic heart Disease market applications are: King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (US), HeartWare (U.S.).

Intended Audience:

Middle-East and Africa Ischemic heart disease Equipment manufacturers
Middle-East and Africa Ischemic heart disease Equipment Suppliers
Government and Independent Regulatory Authorities
Research and Development (R&D) Companies
Independent Research Laboratories
Market Research and Consulting Service Providers
Medical Research Laboratories
Regional Analysis of Middle-East and Africa Ischemic heart Disease Market:
Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

The report for Middle-East and Africa Ischemic heart Disease market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585